Results 191 to 200 of about 1,150,504 (225)

A computational study on effect of Cymbopogon citratu and Juniperus virginiana against Spodoptera litura. [PDF]

Sci Rep
Bandi J, Mulpuru V, Naravula J.
europepmc   +1 more source

Early events in TCR signaling - the evolving role of ITAMs. [PDF]

Front Immunol
Love PE, Hatzihristidis T, Bryant J, Gaud G.   +3 more
europepmc   +1 more source

2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D₃R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies. [PDF]

Int J Mol Sci
Guo L, Gao Y, Zhang S, Zhao L, Zhao R, Sun P, Pan X, Zhang W.   +7 more
europepmc   +1 more source

A straightforward method for measuring binding affinities of ligands to proteins of unknown concentration in biological tissues. [PDF]

Chem Sci
Yan B, Bunch J.
europepmc   +1 more source

Structural and Energetic Insights into SARS-CoV-2 Evolution: Analysis of hACE2-RBD Binding in Wild-Type, Delta, and Omicron Subvariants. [PDF]

Int J Mol Sci
Tang C, Lupala CS, Wang D, Li X, Tang LH, Li X.   +5 more
europepmc   +1 more source

Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma

Frontiers in Immunology
Chengcheng Zhang, Linling Wang, Qianzhen Zhang, Junjie Shen, Xia Huang, Meiling Wang, Yi Huang, Jun Chen, Yanmin Xu, Wenxu Zhao, Yanan Qi, Yunyan Li, Yanjiao Ou, Zhi Yang, Cheng Qian   +14 more
doaj   +1 more source

Impact of SARS-CoV-2 RBM Mutations N501Y and E484K on ACE2 Binding: A Combined Computational and Experimental Study. [PDF]

Int J Mol Sci
Rombel-Bryzek A, Petkov P, Lilkova E, Ilieva N, Litov L, Kubus M, Witkowska D.   +6 more
europepmc   +1 more source

Switching It up with New KRAS Inhibitors. [PDF]

J Med Chem
Waterson AG.
europepmc   +1 more source

Measuring attraction to screen devices in early childhood: development of the Affinity-TV and Affinity-Mobile scales. [PDF]

Front Pediatr
Thompson DA, Kaizer LK, Schmiege SJ, Cabrera NJ, Clark L, Ringwood H, Miramontes Valdes E, Tschann JM.   +7 more
europepmc   +1 more source

Aptamer-engaged nanotherapeutics against SARS-CoV-2. [PDF]

Discov Nano
Zhang J, Wang D, Kwok C, Xu L, Famulok M.   +4 more
europepmc   +1 more source